Profil
Dorrit T.
Andersen is currently working as a Regulatory Director at Galecto Biotech ApS.
Prior to this, she worked as a Director-Global Regulatory Affairs at Novo Nordisk A, Manager-Regulatory Affairs at Genmab A and Symphogen A, and Head-Regulatory Affairs at Ciba-Geigy Denmark.
Andersen completed her undergraduate degree at the University of Copenhagen.
Postes actifs de Dorrit T. Andersen
| Sociétés | Poste | Début |
|---|---|---|
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Conseiller Juridique Général | - |
Anciens postes connus de Dorrit T. Andersen
| Sociétés | Poste | Fin |
|---|---|---|
Ciba-Geigy Denmark | Conseiller Juridique Général | - |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Conseiller Juridique Général | - |
| GENMAB A/S | Conseiller Juridique Général | - |
| NOVO NORDISK A/S | Conseiller Juridique Général | - |
Formation de Dorrit T. Andersen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Ciba-Geigy Denmark | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
















